Carlsbad Technology, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 5923 BALFOUR CT, Carlsbad, California (CA) 92008, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 1000135190 · DUNS 968263561
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2021-11-05
- VAIDrug Quality Assurance2019-10-25
- NAIBioresearch Monitoring2019-08-09
- VAIDrug Quality Assurance2016-11-04
- NAIBioresearch Monitoring2014-11-21
- VAIDrug Quality Assurance2014-11-21
- NAIPostmarket Surv. and Epidemiology2011-11-17
- VAIDrug Quality Assurance2011-11-17
- VAIDrug Quality Assurance2011-05-26
- VAIDrug Quality Assurance2010-03-12
- VAIDrug Quality Assurance2009-04-24
Drugs this plant is listed as making
7 distinct drugs across 23 products name this site in their FDA label.
- AcyclovirCarlsbad Technology, Inc.
- Ciprofloxacin HydrochlorideCarlsbad Technology, Inc.
- Diclofenac SodiumCarlsbad Technology, Inc.
- FamotidineCarlsbad Technology, Inc
- GlimepirideCarlsbad Technology, Inc.
- LovastatinCarlsbad Technology, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.